<?xml-stylesheet type="text/xsl" href="https://www.vetnurse.co.uk/utility/feedstylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>New treatment for pruritic dogs claimed to be 45% more effective than Apoquel</title><link>/b/veterinary-nursing-news/posts/new-treatment-for-pruritic-dogs-claimed-to-be-more-50-more-effective-than-apoquel</link><description> Elanco has launched Zenrelia (ilunocitinib), a once-daily tablet for pruritic dogs with atopic dermatitis, flea allergy dermatitis, food allergies and contact allergies, which the company claims is 45% more effective than Apoquel. 
 Zenrelia is a new</description><dc:language>en-US</dc:language><generator>Telligent Community 10</generator></channel></rss>